|   |
| Research Topics: |
| INDEX |
| PRIME 10 |
| cancer 2 |
| cognition 1 |
| covid-19 2 |
| crime 2 |
| culture 1 |
| diabetes 1 |
| herbs 1 |
| kidneys 1 |
| law 1 |
| nutrition 1 |
| physical 1 |
| politics 6 |
| psychology 1 |
| religion 1 |
| soc-media |
| stress 1 |
| vaccine 2 |
| war-confl |
|
Scanned: 2582 Evaluated: 20 Selected: 14 |
| POLITICS   VACCINE PRIME   COVID-19   | ||||||||
Aac19-007 | FDA Doctors Linked Child Deaths to COVID Vaccines - Biden Admin Stayed Silent | |||||||
| Quote: |
Sen. Ron Johnson (R-WI) released the records this week, referenced in a
May 11, 2026, letter directed to Health and Human Services Secretary
Robert F. Kennedy Jr. Investigative journalist Catherine Herridge was
first to report them....
Those 96 deaths are almost certainly a fraction of the real toll. An HHS-commissioned Harvard study found that fewer than one percent of vaccine adverse events are ever reported to VAERS. As of March 2026, VAERS is reporting 39,077 deaths worldwide following COVID-19 vaccination. The FDA memo itself does not extrapolate from that figure, but the systematic underreporting it acknowledges means the true scope of pediatric harm may never be fully known.... FDAs vaccine division director, Dr. Peter Marks, was told in March 2021, weeks after rollout, that the agencys own system for analyzing safety reports was actively hiding red flags. | |||||||
| Article: | https://redstate.com/ben-smith/2026/05/13/fda-doctors-flagged-dead-children-as-covid-vaccine-safety-signals-biden-never-warned-parents-n2202279 https://www.ronjohnson.senate.gov/services/files/240DB68A-E7D9-4684-A4FD-625CFC4E0DA0 | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| COVID-19   VACCINE | ||||||||
Min19-004 | Safety first: should the high tolerability of intramuscular anti-spike COVID-19 monoclonal antibody change our expectations of vaccine safety? | |||||||
| Quote: | These analysis results support the high tolerability of IM-administered adintrevimab, with reactogenicity data broadly comparable to placebo. While the co-administration of vaccines and monoclonal antibodies limit direct comparisons between historical safety reports, findings such as these demonstrate the potential clinical value of controlled head-to-head studies such as the anticipated LIBERTY trial. | |||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.05.08.26352596v1 | |||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.05.08.26352596v1.full-text | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | David Putrino Allison Curtis Meredith Leston Ilker Yalcin Rachael Gerlach Marc Elia Michael Mina, | |||||||
|
Javilk's Research Links for Week 19 Updated 05/16/2026-01:32:07 AM What interests you? What have you found? Tell me! Drop me a note to subscribe or submit something. |